Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  10.40 0.74% 1,410.40 1,409.80 1,410.60 1,416.20 1,399.80 1,404.40 5,600,223 16:29:59
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 15.0 70,943

GlaxoSmithKline 3Q Net Profit Beats Market Forecasts -- Earnings Review

28/10/2020 1:32pm

Dow Jones News


Glaxosmithkline (LSE:GSK)
Historical Stock Chart


From Oct 2020 to Jan 2021

Click Here for more Glaxosmithkline Charts.

By Ian Walker

 

GlaxoSmithKline PLC has reported a market beating third-quarter net profit, and backed its full-year guidance. Here's what you need to know:

 

SALES: Sales for the quarter were 8.65 billion pounds ($11.28 billion) compared with GBP9.39 billion and a forecast of GBP8.82 billion, taken from FactSet and based on 11 analysts forecasts.

 

NET INCOME: Net profit was GBP1.24 billion, beating a consensus of GBP876.2 million, taken from FactSet and based on three analysts forecasts.

 

CORE EPS: Core EPS--a metric closely watched by analysts that strips out one-off items--came in at 35.60 pence and was up 1% on constant exchange rates. This compared with a forecast of 30.40 pence, taken from FactSet and based on 12 analysts estimates.

 

WHAT WE WATCHED:

 

-GUIDANCE: Glaxo reiterated that it expects adjusted EPS to decline by between 1% and 4% at constant rates in 2020, and would be at the lower end of this range on a CER basis. JPMorgan Cazenove had expected the company to direct expectations toward the more negative end of an anticipated drop.

 

-CORONAVIRUS: Chief Executive Emma Walmsley said the company is "urgently advancing" possible Covid-19 solutions with its partners, and expects see data on all of these before the end of the year.

 

-DIVIDENDS: Glaxo kept its fourth-quarter dividend unchanged at 19 pence a share but didn't say anything about the full-year payout. It had previously said the company plans to pay an unchanged dividend of 80 pence a share for the year.

 

Write to Ian Walker at ian.walker@wsj.com

 

(END) Dow Jones Newswires

October 28, 2020 09:17 ET (13:17 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year Glaxosmithkline Chart

1 Year Glaxosmithkline Chart

1 Month Glaxosmithkline Chart

1 Month Glaxosmithkline Chart
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210120 01:43:29